Global Endocrine Testing Market

The endocrine system comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the body’s metabolism, growth, sexual development and function. Endocrine tests help in assessing the normal functioning of the endocrine gland by checking the hormone levels. The tests detect the imbalance in hormonal levels. The various tests, their advantages and uses are described in the report. The endocrine testing market is driven by the increasing incidences of endocrine disorders such as diabetes, thyroid disorders, infertility, etc. This has also resulted in the development of new technologies, which is driving the growth of this market. High development costs required for developing new technologies could impede growth of this market. The opportunities for this market are tremendous as rising incidences of endocrine disorders and increasing health care awareness would require rapid, sensitive and low priced tests. 

Endocrine Testing Market by Test

The endocrine tests are used to test the levels of  Follicle stimulating hormone(FSH), Human Chorionic Gonadotropin (hCG), Thyroid Stimulating Hormone(TSH), Dehydroepiandrosterone sulfate (DHEAS), Prolactin, Progesterone, Insulin, Cortisol, Testosterone, Estradiol(E2), Luteinizing Hormone (LH) and others. The incidence of diabetes is increasing worldwide. This would require testing of insulin levels. Also, the cases of thyroid disorders are increasing which would further increase the demand for the tests.

Endocrine Testing Market by Diagnostic Technology

The endocrine tests are Immunoassay, Clinical Chemistry tests, tests utilizing Monoclonal and Polyclonal Antibody, and Tandem Mass Spectroscopy. Mass spectroscopy analysis is the most recent technology available. The sensitivity of the tests using mass spectroscopy is very high.

Endocrine Testing Market by end user

The endocrine tests are used in Hospitals, Physicians Offices, Health Care centers, Commercial Laboratories, etc. Hospitals are the major users for these tests with a large number of people visiting hospitals for testing.

Endocrine Testing Market by Geography

The endocrine testing market is segmented into North America, Europe, Asia Pacific and RoW. The market is dominated by North America followed by Europe, as there is greater awareness in these regions. However, the market in Asia-Pacific is expected to grow as the incidences of endocrine disorders are rising in these regions.

Competitive Analysis

The key players in this market are Quest Diagnostics, Thermo Fisher Scientific, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Agilent Technologies, Abbott Laboratories and others. In May 2012, Quest Diagnostics announced four new tests panels for congenital adrenal hyperplasis (CAH), an endocrine disorder. The tests promise to provide faster and high quality diagnosis of CAH.

High Level Analysis

According to Porter’s five force model, the bargaining power of the buyer is high in this market, as there are a wide range of test kits manufactured by many companies. The threat posed by new entrants is also analyzed. The key drivers, restraints and opportunities are described to help in better understanding the market. Business strategies implemented by competitors are analyzed. The value chain analysis of the endocrine testing market is strategically dealt with in the report. 

Key Benefits

• Market segmentation by technology helps in understanding the current technologies as well as future developments on this front
• In- depth analysis of tests used would help in identification of future applications
• Market estimates for the period of 2012-2020 are given, which would give a clear idea of current and future prospects for the market 
• Key factors influencing the market are given which would enable a better understanding of the growth of this market
• Geographic segmentation would help in identifying untapped regions where expansion could be possible

 Global Endocrine Testing Market Report Highlights